InspireMD, Inc.
NSPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 41.9% | 16.3% | -21.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.2% | 17.6% | 19.1% | 24.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -499.4% | -726.2% | -743.1% | -476.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -503.7% | -739.7% | -730.3% | -470.7% |
| EPS Diluted | -0.17 | -0.26 | -0.22 | -0.19 |
| % Growth | 34.6% | -18.2% | -15.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |